Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
13.60
+0.08 (0.59%)
At close: Mar 5, 2026, 4:00 PM EST
15.90
+2.30 (16.91%)
Pre-market: Mar 6, 2026, 6:49 AM EST
Omada Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 260.21 | 169.8 | 122.78 | 89.19 |
| Revenue Growth (YoY) | 53.24% | 38.29% | 37.67% | - |
| Cost of Revenue | 89.27 | 66.92 | 52.81 | 46.39 |
| Gross Profit | 170.94 | 102.88 | 69.97 | 42.79 |
| Selling, General & Admin | 142.23 | 110.61 | 102.23 | 88.97 |
| Research & Development | 40.68 | 35.92 | 33.74 | 26.17 |
| Operating Expenses | 182.91 | 146.53 | 135.97 | 115.14 |
| Operating Income | -11.97 | -43.65 | -66 | -72.35 |
| Interest Expense | -2.53 | -4.51 | -4.71 | -4.2 |
| Interest & Investment Income | 5.31 | 0.81 | 5.78 | 2.2 |
| Other Non Operating Income (Expenses) | -1.47 | 0.22 | -1.05 | 1.83 |
| EBT Excluding Unusual Items | -10.67 | -47.14 | -65.98 | -72.52 |
| Other Unusual Items | -2.11 | - | -1.54 | - |
| Pretax Income | -12.78 | -47.14 | -67.51 | -72.52 |
| Net Income | -12.78 | -47.14 | -67.51 | -72.52 |
| Net Income to Common | -12.78 | -47.14 | -67.51 | -72.52 |
| Shares Outstanding (Basic) | 37 | 8 | 7 | 7 |
| Shares Outstanding (Diluted) | 37 | 8 | 7 | 7 |
| Shares Change (YoY) | 374.52% | 8.89% | 4.59% | - |
| EPS (Basic) | -0.35 | -6.10 | -9.52 | -10.70 |
| EPS (Diluted) | -0.35 | -6.10 | -9.52 | -10.70 |
| Free Cash Flow | 16.93 | -34.78 | -50.15 | -69.7 |
| Free Cash Flow Per Share | 0.46 | -4.50 | -7.07 | -10.28 |
| Gross Margin | 65.69% | 60.59% | 56.99% | 47.98% |
| Operating Margin | -4.60% | -25.71% | -53.75% | -81.12% |
| Profit Margin | -4.91% | -27.76% | -54.98% | -81.31% |
| Free Cash Flow Margin | 6.51% | -20.48% | -40.85% | -78.15% |
| EBITDA | -6.48 | -38.85 | -61.55 | -68.02 |
| EBITDA Margin | -2.49% | -22.88% | -50.13% | -76.27% |
| D&A For EBITDA | 5.49 | 4.8 | 4.45 | 4.33 |
| EBIT | -11.97 | -43.65 | -66 | -72.35 |
| EBIT Margin | -4.60% | -25.71% | -53.75% | -81.12% |
| Revenue as Reported | 260.21 | 169.8 | 122.78 | 89.19 |
| Advertising Expenses | - | 0.5 | 0.8 | 0.7 |
Source: S&P Capital IQ. Standard template.
Financial Sources.